FRANKFURT -- Shares in German drug and chemicals maker Bayer AG BAYG.DE rose sharply on Thursday after it won another legal victory over compensation claims relating to withdrawn cholesterol treatment Baycol. A U.S. federal court on Wednesday denied certification of a class action filed against the firm over Baycol, a drug withdrawn in August 2001 and now linked with more than 100 deaths.
Posted by Editor at September 18, 2003 05:14 PM